Allogeneic CAR-NK cell therapy

CAR-NK cell therapy · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic CAR-NK cell therapy, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC) [EARLY_Phase 1]

See pricing